蛋白質體學服務市場規模、佔有率和成長分析:按服務類型、應用、最終用戶和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2054268

蛋白質體學服務市場規模、佔有率和成長分析:按服務類型、應用、最終用戶和地區分類-2026-2033年產業預測

Proteomics Services Market Size, Share, and Growth Analysis, By Service Type, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球蛋白質體學服務市場價值為 75 億美元,預計到 2033 年將從 2025 年的 84.3 億美元成長到 214.8 億美元,預測期(2026-2033 年)的複合年成長率為 12.4%。

蛋白質體學服務市場正經歷顯著成長,這主要得益於對高解析度蛋白質表徵需求的不斷成長,而高解析度蛋白質表徵對於將分子生物學見解應用於標靶治療和診斷至關重要。質譜分析、蛋白質定量和生物標記發現等服務對於深入了解基因組學以外的細胞功能和疾病機制至關重要。市場正從學術機構轉向提供標準化工作流程的私人公司,其中合約研究組織 (CRO) 為腫瘤學和生物製藥領域提供臨床級解決方案。質譜和數據分析技術的進步提高了靈敏度和處理能力,使得低表現蛋白質的檢測更加便利。此外,人工智慧正在透過改進數據解讀和實驗設計,革新該領域,使服務實驗室能夠有效管理複雜的研究並加速生物標記的發現。

全球蛋白質體學服務市場的成長要素

全球蛋白質體學服務市場的主要促進因素之一是人們對個人化醫療的日益關注,以及蛋白質體學研究在藥物發現和生物標記鑑定中日益重要的地位。隨著醫療保健向個人化治療方案轉變,深入了解蛋白質及其功能的需求變得至關重要。這一趨勢得益於質譜和生物資訊學等技術的進步,這些技術能夠實現更精確、更高通量的蛋白質分析。除了對高效診斷工具日益成長的需求外,學術機構和生物技術公司之間不斷擴大的合作也進一步推動了蛋白質組學服務的發展,並增強了各個治療領域的研究能力。

全球蛋白質體學服務市場的限制因素

全球蛋白質體學服務市場的主要限制因素之一是先進蛋白質體學技術和服務的高成本。蛋白質體學研究的複雜性需要對精密設備、熟練人員、試劑和耗材進行大量投資,這可能會限制小規模研究機構和實驗室的參與。此外,樣品製備和數據分析過程中耗時且複雜的步驟也會阻礙潛在用戶,尤其是在資金有限的地區。因此,這些財務和營運方面的挑戰可能會阻礙蛋白質體學服務市場的成長,尤其是在預算限制尤為突出的新興經濟體。

全球蛋白質體學服務市場趨勢

全球蛋白質體學服務市場正經歷著向人工智慧驅動的工作流程整合的顯著轉變,反映出資料處理和胜肽段鑑定領域對自動化的日益重視。服務供應商正利用機器學習來簡化操作、最大限度地減少人為錯誤並優先處理具有生物學意義的訊號,最終使實驗隊列的分析更加高效且可擴展。智慧數據管理、實驗室自動化和雲端運算的融合進一步強化了這一趨勢,加速了將蛋白質組學數據轉化為可用於藥物發現和生物標記開發的實用見解的過程。隨著對分析資料集的需求持續成長,服務交付模式正日益演變為結合實驗室分析和計算分析的混合夥伴關係,從而推動市場發展。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球蛋白質體學服務市場規模:按服務類型分類

  • 蛋白質鑑定服務
  • 蛋白質定量服務
  • 蛋白質定序服務
  • 生物標記發現服務
  • 蛋白質表徵服務
  • 生物資訊學和數據分析服務
  • 樣品預處理服務
  • 客製化蛋白質體學服務
  • 其他

全球蛋白質體學服務市場規模:按應用領域分類

  • 藥物發現與開發
  • 臨床診斷
  • 生物標記發現
  • 精準醫療
  • 疾病調查
  • 農業和食品調查
  • 毒性測試
  • 其他

全球蛋白質體學服務市場規模:依最終用戶分類

  • 製藥和生物技術公司
  • 學術研究機構
  • 受託研究機構(CRO)
  • 醫院/診斷檢查室
  • 政府和監管機構
  • 食品和農業公司
  • 其他

全球蛋白質體學服務市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Thermo Fisher Scientific
  • Danaher Corporation
  • Agilent Technologies
  • Bruker Corporation
  • Bio-Rad Laboratories
  • Eurofins Scientific
  • Charles River Laboratories
  • QIAGEN
  • Merck KGaA
  • Sartorius AG
  • Seer, Inc.
  • Creative Proteomics
  • Biognosys AG
  • Olink Holding AB
  • SomaLogic Operating Co., Inc.
  • Applied Biomics Inc.
  • Proteome Factory AG
  • Evotec SE
  • SGS SA
  • WuXi AppTec

結論與建議

簡介目錄
Product Code: SQMIG35J2314

Global Proteomics Services Market size was valued at USD 7.5 Billion in 2024 and is poised to grow from USD 8.43 Billion in 2025 to USD 21.48 Billion by 2033, growing at a CAGR of 12.4% during the forecast period (2026-2033).

The proteomics services market is experiencing significant growth driven by an increasing demand for high-resolution protein characterization, essential for translating molecular biology findings into targeted therapies and diagnostics. Services such as mass spectrometry analysis, protein quantification, and biomarker discovery are pivotal as they provide insights into cellular functions and disease mechanisms beyond genomics. The market has transitioned from academic to commercial entities offering standardized workflows, with contract research organizations delivering clinical-grade solutions for oncology and biopharma applications. Technological advancements in mass spectrometry and data analytics have enhanced sensitivity and throughput, facilitating the detection of low-abundance proteins. Additionally, AI is revolutionizing the field by improving data interpretation and experimental design, enabling service labs to efficiently manage complex studies and accelerate biomarker discovery.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Proteomics Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Proteomics Services Market Segments Analysis

Global proteomics services market is segmented by service type, application, end user and region. Based on service type, the market is segmented into Protein Identification Services, Protein Quantification Services, Protein Sequencing Services, Biomarker Discovery Services, Protein Characterization Services, Bioinformatics & Data Analysis Services, Sample Preparation Services, Custom Proteomics Services and Others. Based on application, the market is segmented into Drug Discovery & Development, Clinical Diagnostics, Biomarker Discovery, Precision Medicine, Disease Research, Agricultural & Food Research, Toxicology Studies and Others. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories, Government & Regulatory Organizations, Food & Agricultural Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Proteomics Services Market

One key market driver for the Global Proteomics Services Market is the increasing focus on personalized medicine and the growing significance of proteomic research in drug development and biomarker discovery. As healthcare shifts towards tailored treatment approaches, the need for in-depth understanding of proteins and their functions becomes paramount. This trend is bolstered by advancements in technologies such as mass spectrometry and bioinformatics, which facilitate more accurate and high-throughput protein analysis. The rising demand for efficient diagnostic tools, coupled with an expanding number of collaborations between academic institutions and biotech companies, further propels the growth of proteomics services, enhancing research capabilities in various therapeutic areas.

Restraints in the Global Proteomics Services Market

One key market restraint for the global proteomics services market is the high cost associated with advanced proteomic technologies and services. The complexity of proteomics research requires sophisticated equipment, skilled personnel, and significant investment in reagents and consumables, which may limit access for smaller research institutions and laboratories. Additionally, the lengthy and intricate processes involved in sample preparation and data analysis can deter potential users, especially in regions with limited funding. As a result, these financial and operational challenges can hinder the growth of the proteomics services market, particularly in emerging economies where budget constraints are more pronounced.

Market Trends of the Global Proteomics Services Market

The Global Proteomics Services market is experiencing a significant shift towards the integration of AI-enabled workflows, reflecting a growing preference for automation in data processing and peptide identification. Service providers are leveraging machine learning to streamline operations, minimize human error, and prioritize biologically relevant signals, ultimately leading to more efficient and scalable analyses of experimental cohorts. This trend is further enhanced by the merging of intelligent data curation with laboratory automation and cloud computing, which accelerates the translation of proteomic data into actionable insights for drug discovery and biomarker development. As demand for analyzed datasets continues to rise, service offerings are increasingly evolving towards hybrid partnerships that combine laboratory and computational analytics, driving the market forward.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Proteomics Services Market Size by Service Type & CAGR (2026-2033)

  • Market Overview
  • Protein Identification Services
  • Protein Quantification Services
  • Protein Sequencing Services
  • Biomarker Discovery Services
  • Protein Characterization Services
  • Bioinformatics & Data Analysis Services
  • Sample Preparation Services
  • Custom Proteomics Services
  • Others

Global Proteomics Services Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Drug Discovery & Development
  • Clinical Diagnostics
  • Biomarker Discovery
  • Precision Medicine
  • Disease Research
  • Agricultural & Food Research
  • Toxicology Studies
  • Others

Global Proteomics Services Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Hospitals & Diagnostic Laboratories
  • Government & Regulatory Organizations
  • Food & Agricultural Companies
  • Others

Global Proteomics Services Market Size & CAGR (2026-2033)

  • North America (Service Type, Application, End User)
    • US
    • Canada
  • Europe (Service Type, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Service Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Service Type, Application, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Service Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Proteomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biognosys AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olink Holding AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SomaLogic Operating Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Biomics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteome Factory AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evotec SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi AppTec
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations